Liisa Bayko Score: 39
Analyst at
Evercore ISI
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+30.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
73%
11 W / 4 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
69%
9 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
78%
7 W / 2 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
77%
10 W / 3 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
1 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 31, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$33.00
Est. +89%
|
$17.50 | $35.34 |
Target Met
|
$53.80
+207.4%
|
| Oct 29, 2024 |
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
|
BUY |
$35.00
Est. +50%
|
$23.27 | $41.28 |
Target Met
|
$52.34
+124.9%
|
| Oct 10, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$30.00
Est. +66%
|
$18.07 | $28.69 |
Miss
|
$53.80
+197.7%
|
| Jun 25, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$260.00
Est. +17%
|
$222.90 | $326.03 |
Target Met
|
$287.80
+29.1%
|
| Jun 21, 2024 |
Insmed Inc
INSM
|
BUY |
$75.00
Est. +13%
|
$66.19 | $102.78 |
Target Met
|
$97.46
+47.2%
|
| Jun 17, 2024 |
Aerovate Therapeutics Inc
AVTE
|
BUY |
$2.00
Est. +21%
|
$1.65 | $105.00 |
Target Met
|
$2.68
+62.4%
|
| Jun 03, 2024 |
Caribou Biosciences Inc
CRBU
|
BUY |
$3.00
Est. +4%
|
$2.88 | $3.00 |
Bullseye Hit (±1%)
|
$1.66
-42.4%
|
| May 30, 2024 |
Editas Medicine Inc
EDIT
|
BUY |
$7.00
Est. +37%
|
$5.10 | $6.05 |
Miss
|
$2.46
-51.8%
|
| May 28, 2024 |
Insmed Inc
INSM
|
SELL |
$42.00
Est. +9%
|
$46.21 | $60.40 (Low) |
Miss
|
$97.46
-110.9%
|
| May 16, 2024 |
AN2 Therapeutics Inc
ANTX
|
SELL |
$2.00
Est. +12%
|
$2.27 | $0.87 (Low) |
Target Met
|
$4.74
-108.8%
|
| May 15, 2024 |
Akero Therapeutics Inc
AKRO
|
BUY |
$38.00
Est. +87%
|
$20.30 | $58.40 |
Target Met
|
$54.65
+169.2%
|
| Apr 11, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$438.00
Est. +10%
|
$397.58 | $519.88 |
Target Met
|
$450.69
+13.4%
|
| Mar 19, 2024 |
Madrigal Pharmaceuticals Inc
MDGL
|
BUY |
$405.00
Est. +52%
|
$265.68 | $377.46 |
Miss
|
$499.76
+88.1%
|
| Nov 02, 2022 |
Biocryst Pharmaceuticals Inc.
BCRX
|
BUY |
$16.00
Est. +29%
|
$12.39 | - | - |
$9.06
-26.9%
|
| Sep 13, 2022 |
Akero Therapeutics Inc
AKRO
|
BUY |
$50.00
Est. +72%
|
$29.05 | - | - |
$54.65
+88.1%
|
Travere Therapeutics Inc
TVTX
Oct 31, 2024
Signal & Target
BUY
$33.00
Start Price
$17.50
Best Price (1Y)
$35.34
Current Price
$53.80
Return
+207.4%
Signal & Target
BUY
$35.00
Start Price
$23.27
Best Price (1Y)
$41.28
Current Price
$52.34
Return
+124.9%
Travere Therapeutics Inc
TVTX
Oct 10, 2024
Signal & Target
BUY
$30.00
Start Price
$18.07
Best Price (1Y)
$28.69
Current Price
$53.80
Return
+197.7%
Alnylam Pharmaceuticals Inc
ALNY
Jun 25, 2024
Signal & Target
BUY
$260.00
Start Price
$222.90
Best Price (1Y)
$326.03
Current Price
$287.80
Return
+29.1%
Insmed Inc
INSM
Jun 21, 2024
Signal & Target
BUY
$75.00
Start Price
$66.19
Best Price (1Y)
$102.78
Current Price
$97.46
Return
+47.2%
Aerovate Therapeutics Inc
AVTE
Jun 17, 2024
Signal & Target
BUY
$2.00
Start Price
$1.65
Best Price (1Y)
$105.00
Current Price
$2.68
Return
+62.4%
Caribou Biosciences Inc
CRBU
Jun 03, 2024
Signal & Target
BUY
$3.00
Start Price
$2.88
Best Price (1Y)
$3.00
Current Price
$1.66
Return
-42.4%
Editas Medicine Inc
EDIT
May 30, 2024
Signal & Target
BUY
$7.00
Start Price
$5.10
Best Price (1Y)
$6.05
Current Price
$2.46
Return
-51.8%
Insmed Inc
INSM
May 28, 2024
Signal & Target
SELL
$42.00
Start Price
$46.21
Best Price (1Y)
$60.40
Current Price
$97.46
Return
-110.9%
AN2 Therapeutics Inc
ANTX
May 16, 2024
Signal & Target
SELL
$2.00
Start Price
$2.27
Best Price (1Y)
$0.87
Current Price
$4.74
Return
-108.8%
Akero Therapeutics Inc
AKRO
May 15, 2024
Signal & Target
BUY
$38.00
Start Price
$20.30
Best Price (1Y)
$58.40
Current Price
$54.65
Return
+169.2%
Vertex Pharmaceuticals, Inc.
VRTX
Apr 11, 2024
Signal & Target
BUY
$438.00
Start Price
$397.58
Best Price (1Y)
$519.88
Current Price
$450.69
Return
+13.4%
Madrigal Pharmaceuticals Inc
MDGL
Mar 19, 2024
Signal & Target
BUY
$405.00
Start Price
$265.68
Best Price (1Y)
$377.46
Current Price
$499.76
Return
+88.1%
Biocryst Pharmaceuticals Inc.
BCRX
Nov 02, 2022
Signal & Target
BUY
$16.00
Start Price
$12.39
Best Price (1Y)
-
Current Price
$9.06
Return
-26.9%
Akero Therapeutics Inc
AKRO
Sep 13, 2022
Signal & Target
BUY
$50.00
Start Price
$29.05
Best Price (1Y)
-
Current Price
$54.65
Return
+88.1%